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Abstract
Background: Low back pain (LBP) is by far the most prevalent and costly musculoskeletal
problem in our society today. Following the recommendations of the Multinational Musculoskeletal
Inception Cohort Study (MMICS) Statement, our study aims to define outcome assessment tools
for patients with acute LBP and the time point at which chronic LBP becomes manifest and to
identify patient characteristics which increase the risk of chronicity.
Methods: Patients with acute LBP will be recruited from clinics of general practitioners (GPs) in
New Zealand (NZ) and Switzerland (CH). They will be assessed by postal survey at baseline and at
3, 6, 12 weeks and 6 months follow-up. Primary outcome will be disability as measured by the
Oswestry Disability Index (ODI); key secondary endpoints will be general health as measured by
the acute SF-12 and pain as measured on the Visual Analogue Scale (VAS). A subgroup analysis of
different assessment instruments and baseline characteristics will be performed using multiple
linear regression models.
This study aims to examine
1. Which biomedical, psychological, social, and occupational outcome assessment tools are
identifiers for the transition from acute to chronic LBP and at which time point this transition
becomes manifest
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BMC Musculoskeletal Disorders 2008, 9:167 http://www.biomedcentral.com/1471-2474/9/1672. Which psychosocial and occupational baseline characteristics like work status and period of
work absenteeism influence the course from acute to chronic LBP
3. Differences in outcome assessment tools and baseline characteristics of patients in NZ
compared with CH.
Discussion: This study will develop a screening tool for patients with acute LBP to be used in GP
clinics to access the risk of developing chronic LBP. In addition, biomedical, psychological, social,
and occupational patient characteristics which influence the course from acute to chronic LBP will
be identified. Furthermore, an appropriate time point for follow-ups will be given to detect this
transition. The generalizability of our findings will be enhanced by the international perspective of
this study.
Trial registration: [Clinical Trial Registration Number, ACTRN12608000520336]
Background
Low back pain (LBP) is the most prevalent and costly
musculoskeletal disease, potentially leading to permanent
disability [1,2]. For economically advanced societies a
lifetime prevalence of LBP of up to 80%, an annual prev-
alence of up to 60%, and a point prevalence of up to 40%
is estimated [3]. The natural course of LBP is self-limiting
whereas an estimated 10% of patients develop chronic
LBP as defined by duration of more than 12 weeks [4,5].
Though chronic LBP affects only a small group of patients,
it is a high socioeconomic burden exceeding the treatment
of acute LBP significantly [6]. About 30% of these costs are
direct costs caused by medical treatment, whereas 70% are
attributable to indirect costs e.g. loss of production [2].
Hence, it is of high importance to detect patients at risk of
developing chronic LBP at an early stage as well as to iden-
tify modifiable risk and protective factors [7]. Evidence
and outcome-based research is needed to provide infor-
mation on the appropriate assessment of patients with
acute LBP. To identify these patients, prognostic factors of
chronic LBP must be known. According to the biopsycho-
social model the influence of various factors in addition
to severity of LBP has to be taken into account [8,9].
Guidelines already exist for the management of acute LBP
[10], but some of the main questions in acute LBP – which
assessment tools are the best identifiers for patients at risk
for the transition from acute to chronic LBP and at which
time point this transition takes place – are not clearly
answered. Chronic LBP is defined as LBP lasting longer
than 12 weeks [11]. Furthermore, there are inconsistent
findings on cross-country differences in commonly used
patient outcome assessment tools and baseline character-
istics [12-15].
Although screening instruments are not routinely used in
medical practice they can help to detect prognostic factors
in the course of LBP. They should consist of internation-
ally accepted core outcome measures e.g. as recom-
mended by the MMICS Statement and should be
validated on a multinational level [16]. A recent review on
screening instruments for the identification of prognostic
factors for chronicity in patients with LBP reported that
psychological and occupational factors have the highest
reliability in predicting an unfavourable outcome [17].
Therefore, in this study protocol we focus on these factors
in the design of a new comprehensive screening instru-
ment.
Methods
Research plan
Objectives
This study aims to identify outcome assessment tools of
patients with acute LBP which includes defining patient
characteristics at baseline to allow the identification of
patients at risk of developing chronic LBP [7,18-28] and at
which time the chronicity becomes manifest [29-33]. This
study will be undertaken in cohorts of patients in both
New Zealand (NZ) and Switzerland (CH) to establish any
similarities and differences between them [12-15].
Hypotheses
Three hypotheses will be examined:
1. Specific biomedical, psychological, social, and occupa-
tional outcome assessment tools are identifiers for the
transition from acute to chronic LBP at a time point
between 3 and 12 weeks.
2. Specific psychosocial and occupational baseline charac-
teristics like work status and period of work absenteeism
influence the course from acute to chronic LBP.
3. There are differences in patient outcome assessment
tools and baseline characteristics between patients in NZ
and CH, e.g. in disability compensation systems.Page 2 of 9
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In this two arm cohort study, patients will be recruited
from GP clinics in NZ and CH. Participants will be
assessed directly after attending their GP for LBP treat-
ment for the first time or for recurrent LBP after a pain free
period of at least 6 months (T0) with follow-up at 3, 6,
and 12 weeks, and at 6 months (T1-4). 6 months are the
cut-off point in follow-up as longer follow-ups may incor-
porate additional errors affecting the identification of pre-
dictors.
The study protocol has been approved by the Lower South
Regional Ethics Committee (LRS/08/03/008).
Inclusion and exclusion criteria
We defined broad inclusion criteria to ensure that the
spectrum of patients represents the spectrum seen in rou-
tine settings: consecutive patients attending a GP clinic for
acute LBP in Otago and Waikato districts, NZ and German
speaking CH for a first time or after a pain free period of
at least 6 months; a minimum age of 18 years at the time
visiting a GP; a maximum age of 65 years; a good under-
standing of English or German; and a signed consent, are
required.
Exclusion criteria are: chronic LBP (defined as LBP contin-
uing for more than 12 weeks at time of first visit to GP)
[11,30]; specific LBP (infection, tumour, osteoporosis,
ankylosing spondylitis, fracture, deformity, inflammatory
process, cauda equina syndrome) [10]; comorbidity that
determines overall well-being (e.g. painful disabling
arthritic hip joints); pregnancy; expected loss to follow-up
(e.g. due to moving from the district); and unwillingness
to complete questionnaires (Table 1).
Outcome assessment
Demographic and baseline characteristics
The following demographic, biomedical, psychological,
social, and occupational factors will be assessed at base-
line according to the recommendations of the MMICS
Statement:
- Gender [34,35]
- Age [32,36-38]
- BMI
- Ethnicity
- ODI [39,40]
- Acute SF-12 [41]
- Quality and intensity of LBP (SF-McGill including VAS)
[42-44]
- LBP history (duration and recurrence) [45-48]
- Radiating leg pain below the knee
- Lifestyle factors (exercise, smoking, alcohol consump-
tion) [49-52]
- Depression (modified self-rating depression scale by
Zung ZUNG) [53,54]
- Somatisation (Modified Somatic Perceptions Question-
naire MSPQ) [55]
- Fear avoidance beliefs (Fear Avoidance Beliefs Question-
naire FABQ) [56-58]
- Pain catastrophizing (Pain Catastrophizing Scale PCS)
[59]
- Marital/relationship status
- Social support
- Educational status
- Employment/work status
- Job satisfaction [35,60-62]
- Job control [35,63]
- Work stress factors [61,62,64-67]
- Belief that work has caused LBP [68-70]
Table 1: Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
1. Patients attending GP clinic with acute LBP 1. Chronic LBP
2. Age 18–65 years 2. Specific LBP
3. Good understanding of English (NZ) or German (CH) 3. Comorbidity determining overall well-being
4. Written consent 4. Pregnancy
5. Expected loss to follow-up
6. Unwillingness to complete questionnairesPage 3 of 9
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- Reasons for not working
- Disability compensation status [74-79]
- Patients' expectations on return to work [80-82].
Outcome measures
ODI, acute SF-12, and VAS pain score are among the most
frequently used outcome assessment measurements of
LBP. All of them are valid and reliable. In this study of out-
come predictors, the primary endpoint for chronicity is
ODI. Key secondary endpoints are acute SF-12 and VAS
pain score.
Other secondary outcomes that will be collected by
patient self-assessment as recommended by the MMICS
Statement are: reduction in normal activities due to LBP;
health care utilization including treatment received and
referral as provided by the Accident Compensation Cor-
poration (ACC) and GPs; medication [83]; modified self-
rating depression scale by Zung (ZUNG); Modified
Somatic Perceptions Questionnaire MSPQ (MSPQ); Fear
Avoidance Beliefs Questionnaire (FABQ); Pain Catastro-
phizing Scale (PCS); patient satisfaction with condition
and care; return to work (RTW); and sick leave over the
last week.
Data management
Database
Patient data will be stored at a central database at the Uni-
versity of Otago (UoO), Dunedin, in strictly anonymised
fashion. Data will be analysed in cooperation with a stat-
istician in the Department of Preventive and Social Medi-
cine, Dunedin School of Medicine. Data will be double
entered and cleaned before use.
Statistical analysis
Multivariate identification of predictors for chronicity
Changes in primary and secondary endpoints between
baseline data and different time points of follow-up will
be analysed by multiple linear regression models. Patients
with chronic LBP at 6 months follow-up will be compared
with patients without chronic LBP at the same time point.
Patients with chronic LBP in this study are defined as
patients with an ODI score without improvement by a
Minimal Clinically Important Difference (MCID) of 10
ODI points between T0 (attending the GP for the first
time or after a pain free period of at least 6 months) and
T4 (6 months follow-up) [84-87].
An analysis of different assessment instruments and base-
line characteristics will be performed to find appropriate
scores or patient characteristics to identify patients at risk
to develop chronic LBP. Different patient assessment tools
will be allocated to the following four groups: demo-
graphic-biomedical, psychological, social, and occupa-
tional risk group [88]. We aim to detect at least one
assessment instrument in each group which identifies
patients at risk.
Identification of time of chronicity
In a second step, a subgroup analysis on patients without
chronic LBP will be performed to identify the time of fol-
low-up (TX) where this patient group shows an improve-
ment in ODI by at least the MCID. As patients with
chronic LBP by definition of their condition don't show
an improvement at TX, this follow-up is the most appro-
priate time point for detecting the transition from acute to
chronic LBP in patients at risk.
Sample size/power calculation
Sample size considerations
Sample size considerations in clinical studies start from
what is considered a MCID. In studies of chronic LBP, the
ODI is commonly used as the main outcome measure,
and a difference in 10 ODI points is considered clinically
relevant. We will consider the sample size and power
according to the MCID of ODI.
A minimum of 10 patients with chronic LBP are needed to
produce stable estimates for each predicting variable. We
will collect data on e.g. 20 potential predictive factors and
screen these by logistic regression. If assuming we select
four of these predictors for regression modelling, looking
for an independent effect, then at least 40 patients with
chronic LBP will be needed, 10 patients for each predictor.
We considered a series of scenarios for sample size calcu-
lations which resulted in an array of sample sizes between
200 and 800 patients necessary to ensure 80% power at a
two-sided p of 0.05. If 5% of patients with acute LBP
develop chronic LBP, 800 patients will have to be ana-
lysed. However, if 10% or 20% develop chronic LBP at 6
months follow-up only 400 and 200 patients respectively
will be needed. Trends from our pilot study including 20
patients in Otago district, NZ show that an even smaller
sample size might be sufficient – due to a rate of chronic
patients of up to 30% in the pilot sample.
Feasibility of the study
Patient recruitment
Patients in NZ will be recruited consecutively and pro-
spectively in collaboration between the Department of
Orthopaedic Surgery at Dunedin Hospital, UoO, and Best
Practice Advocacy Centre Incorporated (BPAC Inc), Dun-
edin. GPs cooperating with BPAC Inc will ask patients
who meet the study eligibility criteria to give their consentPage 4 of 9
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ticipate in our study. Patients who give their consent may
be given a detailed information sheet by their GPs about
the study including contact details of the study coordina-
tor. On the same day, contact details (telephone number,
postal and email address) of these patients will be elec-
tronically forwarded in an automated fashion from the
GP clinics to the research group at the UoO.
Patient assessment at different time points in our study
will be conducted by research nurses at the UoO. At base-
line a short screening interview on the telephone will be
performed following a structured questionnaire. This
interview will check the eligibility for enrolment (see
inclusion criteria, Table 1). When a patient is classified as
eligible, a document stating their signed consent and a
first set of questionnaires (T0) will be sent out by post on
the same day. At follow-up times (T1-4) research nurses
will collect these patient-derived questionnaires and enter
them into the central database. If not returning the ques-
tionnaire a first reminder will be sent out after one and a
second after two weeks.
To optimise the number of completed questionnaires
patients will be able to choose between a $NZ10 fuel,
supermarket or book voucher as compensation for their
expenditure of time after return of each of the five ques-
tionnaires. This level of compensation will not encourage
unwilling participation. GPs will be compensated with
the same choice of voucher for every referred patient.
Patients in CH will be recruited consecutively and pro-
spectively at the realHealth Centre, Nottwil. Patient
assessment and follow-ups will be conducted in parallel
to the study arm in NZ by a research group headed by NA.
Data collection
2220 patients will be assessed for eligibility in NZ and CH
respectively (Figure 1). It can be assumed that 75% of
these screened patients will be found eligible for enrol-
ment. Out of these 1650 patients it is estimated that 990
(60%) will agree to participate in this study. Up to 20% of
the patients can be expected to be lost to follow-up, in the
worst case scenario, so that an estimated 792 patients will
be analysed.
The expected duration of the data collection phase of the
study will be two years, comprising one and a half years of
patient recruitment overlapping with two years of follow-
up.
Discussion
Scientific significance
LBP is by far the most prevalent and most costly muscu-
loskeletal problem in our society today [6,10,89,90].
Despite numerous previous studies, to our knowledge
there has not been an attempt to comprehensively assess
all potential factors which lead to the transition from
acute to chronic LBP and the point in the disease progres-
sion when this occurs [7].
This study will assess a core set of outcome assessment
tools for patients with acute LBP in a GP setting to assess
which factors predict whether these patients are at risk of
developing chronic LBP [91,92]. In addition, biomedical,
psychological, social, and occupational baseline charac-
teristics will be identified which may be found to influ-
ence the course from acute to chronic LBP. Furthermore,
an appropriate time for follow-ups will be given to
increase the likelihood of detecting this transition.
The international perspective of this study of patients in
NZ and CH will be an asset in terms of generalizability
and validation of our findings for use by others.
Social and economic significance
The knowledge about the ideal assessment of predicting
factors will help GPs to prevent patients from developing
chronic LBP [90,93-98]. This might result in saving treat-
ment and rehabilitation costs of chronic LBP for the ben-
efit of health care providers and consumers [99].
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